Clinical Trials in Baltimore

Showing 8761-8780 of 23,476 trials

COMPLETEDPhase 1< 1 mile

CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL

NCT03739554

A Phase I Combination Study of CYC065 and Venetoclax for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Relapsed or Refractory Chronic Lymphocytic Leukemia

Cyclacel Pharmaceuticals, Inc.5 participantsStarted Jan 2019

Baltimore, Maryland, United States • Charlotte, North Carolina, United States • Houston, Texas, United States

COMPLETEDPhase 1/2< 1 mile

BIO 300 Non-Small Cell Lung Cancer Study

NCT02567799

The purpose of this study is to determine the safety and effectiveness of BIO 300 Oral Suspension when used in combination with standard dose radiation therapy and chemotherapy in patients with non-small cell lung cancer. Based on preclinical data the investigators hypothesize that BIO 300 Oral Suspension will reduce the incidence of radiation-induced pneumonitis and pulmonary fibrosis.

Carcinoma, Non-Small-Cell Lung

Humanetics Corporation21 participantsStarted Nov 2015

Baltimore, Maryland, United States • Detroit, Michigan, United States • Milwaukee, Wisconsin, United States +1 more locations

CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL

BIO 300 Non-Small Cell Lung Cancer Study

Find Trials by Condition in Baltimore

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Clinical Study of the Solo+ Tympanostomy Tube Device

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

rTMS for Neuroenhancement

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide

Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

EPI-743 for Mitochondrial Respiratory Chain Diseases

Incorporating Supersaturated Oxygen in Shock

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip